Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
C.J. DiBlasio; 7/7/2011; Page 1 of 17 North Shore Medical Group of the Mount Sinai School of Medicine Department of Urology 21 Southdown Road●Huntington, New York●11743 Phone: (631) 351-3763 Fax: (631) 385-8210 Department of Urology, University of Tennessee Health Science Center 910 Madison Avenue/Room 409●Memphis, Tennessee●38163 Phone: (901) 448-1026●Fax: (901) 448-1044 Email/Websites: [email protected] http://www.mssm.edu/hospitals/northshore/urology.htm http://www.killcancercold.com/doctor_detail.php?doctorid=263 CHRISTOPHER J. DIBLASIO, M.D. STAFF POSITIONS: Mount Sinai School of Medicine, Department of Urology, Clinical Instructor, New York, New York ; 5/2010 - present North Shore Medical Group of the Mount Sinai School of Medicine Department of Urology, Staff physician, Huntington, New York; 8/2008 – present. The University of Tennessee Health Sciences Center, Department of Urology Clinical Instructor; 8/2008 – present. HOSPITAL AFFILIATIONS: Huntington Hospital, Huntington, New York; 9/23/2008 – present St. Joseph‟s Hospital, Bethpage, New York; 12/11/2008 – present North Shore University/Long Island Jewish Medical Center; 2/18/2009 – present Mount Sinai Hospital, New York, New York; 5/26/2010 – present PROCTORING/PRECEPTORSHIP EXPERIENCE: Healthtronics/Endocare: prostate cryoablation/cryosurgery for primary and radiationrecurrent prostate cancer; 2010 – present EDUCATION Residency: The University of Tennessee, Department of Urology July 2004 - June 2008; Memphis, Tennessee Internship: The University of Tennessee, Department of Surgery July 2003 - June 2004; Memphis, Tennessee Fellowship: Memorial Sloan-Kettering Cancer Center, Department of Urology C.J. DiBlasio; 7/7/2011; Page 2 of 17 July 2002 - June 2003; New York, NY; Uro-oncology Research Fellow Medical: St. George‟s University School of Medicine August 1998 - May 2002; Grenada, West Indies Degree: Doctor of Medicine (M.D.); Cum Laude Undergraduate: Fairfield University September 1994 - June 1998; Fairfield, Connecticut Major: Biology; Minor: Jazz Performance Degree: Bachelor of Science (B.S.); Cum Laude High School: Cold Spring Harbor High School September 1990 - May 1994; Cold Spring Harbor, New York PROFESSIONAL POSITIONS AND SOCIETIES: Allied Metro Medical, Medical Advisory Board, 8/2009 – present. Surgical Care Improvement Project (SCIP) Committee, Huntington Hospital, 10/2009 – present. Cancer Committee, Huntington Hospital, 10/2009 – present. New York Section, American Urological Association, 2008 – present. Alpha Omega Alpha (AOA), 2008 – present. Association of Clinical Urology (AACU), 2007 – present. UROPAC, 2007 – present. New York State Urological Society, Inc., 2007 – present. American Urologic Association (AUA), 2003 – present. Society of Endourology, 2004 – present. HONORS & AWARDS: Residency: Alpha Omega Alpha (AOA) National Medical Honor Society, 2008 American Urologic Association George P. Murphy Honorary Scholar, 2008 2nd Annual National Urology Residency Preceptorship (NURP) in Adult and Pediatric Reconstructive and Prosthetic Urologic Surgery, Cleveland Clinic Foundation, OH, 2006 American Urologic Association George P. Murphy Honorary Scholar, 2006 Peer-selected Resident-Faculty advisor, Department of Urology, 2005 2008 Regional Medical Center Physician Recognition Award (Memphis, TN) for Excellence in Patient Care, 2003 - 2004 Medical School: Iota Epsilon Alpha (International Medical Honor Society; AOA equivalent) Peer-Distinguished Future Physician Award (2000) Dean‟s List of Distinguished Students C.J. DiBlasio; 7/7/2011; Page 3 of 17 Cum Laude graduate Undergraduate: Alpha Epsilon Delta (Pre-medical honor society) Alpha Mu Gamma (Foreign Language Honor Society; Italian) National Dean‟s List United States Achievement Academy‟s All-American Scholar Award Four-year academic merit-based scholarship recipient Dean‟s List of Distinguished Academic Achievement (Four-years) Fairfield University Musical Excellence Award (2002; Most valuable player) Cum Laude graduate RESEARCH: Dedicated Research Positions: University of Tennessee Health Science Center/GTx Inc. Research Study Assistant; July 2005 – November 2005 Mentor(s): Mitchell Steiner, M.D.; Karen Veverka, Ph.D. Project: Metabolism and degree of enterohepatic recirculation of GTx-024 in a rat model Memorial Sloan-Kettering Cancer Center, Department of Urology Research Fellow; July 2002-June 2003 Mentor(s): Peter T. Scardino, M.D.; Michael W. Kattan, Ph.D. Weill-Cornell Medical Center at New York Presbyterian Hospital, Department of Urology Research Study Assistant; September 2001-June 2003 Mentor(s): Jerry G. Blaivas, M.D.; Jeffrey P. Weiss, M.D. Clinical Trials: 1. Focal prostate cryoablation for treatment of low-volume clinically localized prostate cancer. Principal Investigators: C.J. DiBlasio, M.D.; MA. Palese (IRB pending) Publications: Peer Reviewed Articles: 1. Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int., April 2010 (In press) 2. Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Wake RW, Patterson AL, Wan JY, Derweesh IH. Variationn in the incidence of and risk factors for development of nephrolithiasis after radical or partial nephrectomy. BJU Int., Feb. 2010 (In press). 3. DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW. Peyronie‟s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. BJU Int., Jan. 2010 (In press). 4. Mehrazin R, Derweesh I, Giem A, Balazs L, DiBlasio C. Local excision of fibroma of the testicular tunic in a HIV patient. Curr Urol., 2009; 3: 158-60. C.J. DiBlasio; 7/7/2011; Page 4 of 17 5. Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH. Comparison of rates and risk factors for development of chronic renal insufficiency, proteinuria, and metabolic acidosis following radial or partial nephrectomy. BJU Int., 2009 (In press). 6. DiBlasio CJ, Kurta J, Botta S, Malcolm JB, Wan JY, Derweesh IH, Aleman MA, Wake RW. Peyronie‟s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. BJU Int., 2009 (In press). 7. DiBlasio CJ, Bagrodia A, Derweesh IH. Adverse effects of androgen deprivation therapy in prostate cancer. Drug Safety, 2009 (In press). 8. Malcolm JB, Bagrodia A, Derweesh IH, Mehrazin R, DiBlasio CJ, Wake RW, Wan JY, Patterson AL. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria, and metabolic acidosis after radical and partial nephrectomy. BJU Int., 2009 August; 104(4): 476-81. 9. DiBlasio CJ, Malcolm JB, Hammett J, Wan JY, Aleman MA, Patterson AL, Wake RW, Derweesh IH. Survival outcomes in men receiving androgen deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year singlecenter experience. BJU Int., 2009 November; 104(9): 1208-14. 10. Bagrodia A, DiBlasio CJ, Wake RW, Derweesh IH. Adverse effects of androgen deprivation therapy in prostate cancer: current management issues. Indian J Urol., 2009 April; 25(2): 169-76. 11. Derweesh IH, Malcolm JB, DiBlasio CJ, Giem A, Rewcastle JC, Wake RW, Patterson AL and Gold R. Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumors. J Endourol., 2008 Nov; 22(11):2461-7. 12. Nelson CJ, DiBlasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's Disease. J. Sexual Med., 2008 Aug;5(8):1985-90. 13. DiBlasio CJ, Hammett J, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar KD, Derweesh IH, Patterson AL, Wake RW. Patterns of diagnosis and predictive factors for development of psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Canadian J Urol. 2008 Oct;15(5):4249-56. 14. DiBlasio CJ, Derweesh IH, Malcolm JB, Maddox MM, Aleman MA, Patterson AL, Wake RW. Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Intl Braz J Urol. 2008 Jul-Aug;34(4):443-50. 15. Malcolm JB, Derweesh IH, Mehrazin R, DiBlasio CJ, Vance DD, Joshi S, Gold R, Wake RW. Nonoperative management of blunt renal trauma: Is routine early follow-up imaging necessary? BMC Urology, 2008, 8:11. 16. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Jackson S. Sutureless laparoscopic heminephrectomy: Safety and efficacy in physiologic and chronically obstructed porcine kidney. Surg Innov. 2008 Sep;15(3):194-202. 17. Malcolm JB, Derweesh IH, Brightbill KE, Mehrazin R, DiBlasio CJ, and Wake RW. Efficacy of tubeless percutaneous nephrolithotomy for complex renal stone disease: Single center experience. Can J Urol. 2008 Jun;15(3):4072-7. 18. DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. BJU Int. 2008 Jul;102(1):39-43. C.J. DiBlasio; 7/7/2011; Page 5 of 17 19. Derweesh IH, DiBlasio CJ, Malcolm J, Kincade MC, Lamar KD, Patterson AL, Kitabchi AE, Wake RW. Risk of new-onset diabetes mellitus and worsening glycemic parameters for established diabetes in men undergoing androgen deprivation therapy for prostate cancer. BJU Int. 2007 Nov;100(5):1060-5. 20. Malcolm JB, Derweesh IH, Kincade MC, DiBlasio CJ, Lamar KD, Wake RW, Patterson AL. Incidence of osteoporosis and skeletal fractures in men undergoing androgen deprivation therapy for prostate cancer. Can J Urol. 2007 Jun;14(3):3551-9. 21. Masterson TA, Bianco FJ Jr, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, Eastham JA, Scardino PT. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol. 2006 Apr;175(4): 13201325. 22. DiBlasio CJ, Snyder M, Russo P. Mini flank supra-eleventh rib incision: applying minimally-invasive principles to open partial or radical nephrectomy. BJU Int. 2006 Jan;97(1):149-56. 23. Stephenson AJ, Scardino PT, Eastham JA, Bianco Jr. FJ, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin Oncol. 2005 Oct 1; 23 (28): 7005-12. 24. Bianco FJ Jr, Scardino PT, Stephenson AJ, DiBlasio CJ, Fearn PA, Eastham JA. Longterm oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):448-53. 25. Mallah KN, DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer. 2005 May 15;103(10):2030-4. 26. Zahalsky M, Wilson SR, Di Blasio CJ, Lam SK, Nagler HM. Male Infertility on the internet: an analysis of web-based resources. BJU Int. 95(4), 481-484, 2005. 27. Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 172 (6 Pt 1), 2239-2243, 2004. 28. Weiss JP, Blaivas JG, Tash Anger JA, Di Blasio CJ, Panagopoulos G, Gerboc J. Development and validation of a new treatment outcomes score for men with lower urinary tract symptoms (LUTS). Neurourol Urodyn. 23(2), 88-93, 2004. 29. Kondabolu S, Khan SA, Whyard J, DiBlasio C, Ayyala M, Pentyala S. The role of endoluminal ultrasonography in urology: current perspectives. Int. Braz J Urol. 30(2), 96101, 2004. 30. Slawin KM, DiBlasio CJ, Kattan MW. Minimally invasive therapy for prostate cancer: use of nomograms to counsel patients about the choice and probable outcome of therapy. Reviews in Urology. 6(4), 3-8, 2004. 31. DiBlasio CJ, Snyder ME, Kattan MW, Russo P. Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy. J Urol. 171 (3), 1062-1065, 2004. 32. DiBlasio CJ, Kattan MW. The use of nomograms to predict patients for risk of recurrence after definitive local therapy for prostate cancer. Urology. 62 (1), 9-18, 2003. 33. Di Blasio CJ, Rhee A, Cho D, Scardino PT, Kattan MW. Predicting clinical end points: Treatment nomograms in prostate cancer. Seminar Oncol. 30 (5), 567-86, 2003. C.J. DiBlasio; 7/7/2011; Page 6 of 17 34. Cho D, Di Blasio CJ, Rhee AC, Kattan MW. Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen-deprivation therapy (ADT). Urol Oncol. 21 (4), 282-91, 2003. 35. Eastham JA, DiBlasio CJ, Scardino PT. Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy. Curr Urol Rep. 4(3), 211-215, 2003. Book Chapters: Rhee AC, DiBlasio CJ, Cho D, Kattan MW. Predictive outcomes: Artificial neural networks (ANN) and nomograms. In: Klein, EA. Managing Prostate Cancer, 2nd ed., Humana Press, 2003. Abstracts: 1. Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Silberstein J, Downs T, Chenoweth M, Wake RW, Kane CJ, Patterson AL, Wan JY, Derweesh IH. Variations in incidence of and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. Presented at the American Urological Association, 104th Annual Meeting, Chicago, IL, April 2009. 2. Bagrodia A, DiBlasio CJ, Malcolm JB, Mehrazin R, Silberstein J, Chenoweth M, Downs T, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH. Comparison of rates and risk factors for development of anemia following radical nephrectomy or partial nephrectomy. Presented at the American Urological Association, 104th Annual Meeting, Chicago, IL, April 2009. 3. DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW. Peyronie‟s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. Presented at the American Urological Association, 104th Annual Meeting, Chicago, IL, April 2009. 4. Mehrazin R, Brahmbhatt J, Clendenin R, DiBlasio CJ, Wake RW, Derweesh IH, Aleman MA. Inter- and intra-specialty analysis of “dead of disease” versus “dead with disease” in prostate cancer: is this a meaningful study end-point? Presented at the American Urological Association, 104th Annual Meeting, Chicago, IL, April 2009. 5. Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Wake RW, Patterson AL, Wan JY, Derweesh IH. Difference in occurrence of and risk factors for development of nephrolithiasis after radical or partial nephrectomy. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 6. Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH. Comparison of rates and risk factors for development of chronic renal insufficiency, proteinuria, and metabolic acidosis following radial or partial nephrectomy. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 7. Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Patterson AL, Wan JY, Derweesh IH. Variation in incidence of and risk factors for development of osteoporosis after radical or partial nephrectomy. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 8. Mehrazin R, Derweesh IH, Christman M, Bagrodia A, Malcolm JB, DiBlasio CJ, Auge B, L'Esperance J. Is sutured repair necessary during laparoscopic partial nephrectomy. C.J. DiBlasio; 7/7/2011; Page 7 of 17 Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 9. Mehrazin R, Brahmbhatt J, Clendenin R, DiBlasio CJ, Wake RW, Derweesh IH, Aleman MA. Critical analysis of cause of death in prostate cancer patients receiving androgen deprivation therapy. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 10. DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW. Peyronie‟s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 11. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake . Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 12. DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 13. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 14. DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the Southeastern Section American Urological Association 73rd Annual Meeting, Mobile, AL, March 2009. 15. Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical and partial nephrectomy practice patterns during residency training. Presented at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 16. Mehrazin R, DiBlasio CJ, Malcolm JB, Derweesh IH. Initial experience with laparoscopic partial nephrectomy for renal malignancy utilizing non-ischemic resection and sutureless renorrhaphy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 17. Mehrazin R, Malcolm JB, DiBlasio CJ, Wake RW, Patterson AL, Gold R, Derweesh IH. Single center experience and intermediate-term outcomes of laparoscopic and percutaneous renal cryoablation for biopsy confirmed renal malignancy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 18. DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. C.J. DiBlasio; 7/7/2011; Page 8 of 17 19. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt J, Yu C, Aleman MA, Patterson AL, Wake RW, Derweesh IH, Kattan MW. Family history may not predict development of prostate cancer diagnosis: results from a contemporary screening population. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 20. Brahmbhatt J, Mehrazin R, Aleman MA, Derweesh IH, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical prostatectomy practice patterns during residency training. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 21. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 22. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Increasing the number of cores removed during transrectal ultrasound-guided prostate biopsy improves cancer detection. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 23. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block improves cancer detection during transrectal ultrasound-guided prostate biopsy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 24. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Use of statin medications may decrease cancer detection rates during transrectal ultrasound-guided prostate biopsy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 25. DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 26. Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical nephrectomy practice patterns during residency training. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 27. Mehrazin R, DiBlasio CJ, Malcolm JB, Derweesh IH. Initial experience with laparoscopic partial nephrectomy for renal malignancy utilizing non-ischemic resection and sutureless renorrhaphy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 28. Mehrazin R, Malcolm JB, DiBlasio CJ, Wake RW, Patterson AL, Gold R, Derweesh IH. Single center experience and intermediate-term outcomes of laparoscopic and percutaneous renal cryoablation for biopsy confirmed renal malignancy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 29. Mehrazin R, Bagrodia A, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH. Assessment of risk factors for and comparison of rates of development of chronic renal insufficiency, proteinuria and metabolic acidosis following radical or nephron sparing surgery. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. 30. Mehrazin R, DiBlasio CJ, Bagrodia A, Malcolm JB, Wan JY, Wake RW, Patterson AL, C.J. DiBlasio; 7/7/2011; Page 9 of 17 31. 32. 33. 34. 35. 36. 37. 38. Derweesh IH. Variation in incidence of and risk factors for the development of osteoporosis after radical or partial nephrectomy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. Derweesh IH, DiBlasio CJ, Mehrazin R and Swanna HS. Treatment of post transplantation vesicoureteral reflux with injection of dextranomer/hyaluronic acid copolymer. Presented at the 17th Annual Meeting of the Society of Laparoendoscopic Surgeons, Chicago, Il, September 2008. Derweesh IH, Wan JY, DiBlasio CJ, Malcolm JB, Mehrazin R, Patterson AL, Wake RW. Evaluation of urinary tract nuclear matrix protein 22 test for detection of upper tract urothelial carcinoma. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. Derweesh IH, Mehrazin R, Wan JY, DiBlasio CJ, Malcolm JB, Patterson AL, Wake RW. Comparison of rates and risk factors for development of chronic renal insufficiency following radical or partial nephrectomy. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. Derweesh IH, DiBlasio CJ, Wan JY, Malcolm JB, Mehrazin R, Patterson AL, Wake RW. Variation in incidence of and risk factors for development of nephrolithiasis after radical or partial nephrectomy. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. DiBlasio CJ, Maddox MM, Mehrazin R, Malcolm JB, Aleman MA, Derweesh IH, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake . Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Presented at the ASCO Genitourinary Cancers Symposium, San Francisco, CA, February 2008. DiBlasio CJ, Maddox MM, Mehrazin R, Malcolm JB, Aleman MA, Derweesh IH, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the ASCO Genitourinary Cancers Symposium, San Francisco, CA, February 2008; Selected as part of the ASTRO/ARRO (Association of Residents in Radiation Oncology) poster walk*. 39. Malcolm JB, Mehrazin R, DiBlasio CJ, Vance DD, Derweesh IH, and Wake RW. Nonoperative management of blunt renal trauma: is routine follow-up imaging necessary? Accepted for presentation at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. 40. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Wake RW. Prospective comparison of „sutureless‟ laparoscopic partial nephrectomy and „conventional‟ laparoscopic partial nephrectomy: initial experience and results. Accepted for presentation at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. C.J. DiBlasio; 7/7/2011; Page 10 of 17 41. DiBlasio CJ, Ganguli S, Walls K, Malcolm JB, Wan JY, Derweesh IH, Aleman MA and Wake RW. Histologic changes associated with chronic indwelling bladder catheters in a contemporary cohort of spinal cord injury patients. Accepted for presentation at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. 42. DiBlasio CJ, Maddox MM, Malcolm JB, Lamar KD, Derweesh IH, Aleman MA, and Wake RW. Voiding dysfunction following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Accepted for presentation at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. 43. DiBlasio CJ, Maddox MM, Malcolm JB, Lamar KD, Derweesh IH, Aleman MA and Wake RW. Patterns of sexual and erectile dysfunction and response to treatment following primary targeted cryoablation of the prostate for localized prostate cancer. Accepted for presentation at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. 44. Malcolm JB, Derweesh IH, DiBlasio CJ, Satpathy B, Walls KM, Bagrodia A, Roberts M, Lambert JW, and Patterson AL. Upper tract complications and renal functional outcomes following ileal conduit urinary diversion. Presented at the Society of Urologic Oncology 8th Annual Meeting, Bethesda, MD, November 2007. 45. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Mehrazin R, Wan JY, Aleman MA, Derweesh IH, Patterson AL and Wake RW. Survival outcomes in men treated with androgen deprivation therapy as primary or salvage therapy: 20 year single-center experience. Presented at the Society of Urologic Oncology 8th Annual Meeting, Bethesda, MD, November 2007. 46. Derweesh IH, Malcolm JB, DiBlasio CJ, Hughes S, Mehrazin R, Patterson AL and Wake RW. Efficacy of nuclear matrix protein 22 assay for detection of upper tract urothelial carcinoma. Presented at the Society of Urologic Oncology 8th Annual Meeting, Bethesda, MD, November 2007. 47. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Bargodia A and Wake RW. Prospective comparison of “sutureless” laparoscopic partial nephrectomy vs. “conventional” laparoscopic partial nephrectomy: initial experience and results. Presented at the 25th World Congress of Endourology, Cancun, Mexico, November 2007. 48. Derweesh IH, Rewcastle JC, Wake RW, Malcolm JB, DiBlasio CJ, Giem A, Patterson AL, and Gold R. Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumor. Presented at the 25th World Congress of Endourology, Cancun, Mexico, November 2007. 49. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Jackson S. Sutureless Laparoscopic Heminephrectomy: Safety and Efficacy in the Porcine Model. Presented at the 16th Society of Laparoendoscopic Surgeons Annual Meeting and Expo 2007, San Francisco, CA, September 2007. C.J. DiBlasio; 7/7/2011; Page 11 of 17 50. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Chichakli R. Preliminary Experience with Sutureless Laparoscopic Partial Nephrectomy for Renal Tumors with Collecting System Entry: Technique and Results. Presented at the 16th Society of Laparoendoscopic Surgeons Annual Meeting and Expo 2007, San Francisco, CA, September 2007. 51. Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Jackson S. Sutureless laparoscopic heminephrectomy: Safety and efficacy in physiologic and chronically obstructed porcine kidney. Presented at the Engineering in Urology Society Meeting, Anahiem, CA, May 2007. 52. Nelson CJ, DiBlasio CJ, Kendirci M, Hellstrom W, Mulhall JP. The chronology of depression and distress in men with peyronie‟s disease. Presented at the American Urological Association, 102nd Annual Meeting, Anaheim, Ca, May 2007. 53. Malcolm JC, Mehrazin R, DiBlasio CJ, Vance DD, Wake RW, Derweesh IH. Nonoperative management of blunt renal trauma: is routine follow-up imaging necessary?. Accepted for presentation at the American Urological Association, 102nd Annual Meeting, Anaheim, Ca, May 2007. 54. DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. Presented at the American Urological Association, 102nd Annual Meeting, Anaheim, Ca, May 2007. 55. Malcolm JB, DiBlasio CJ, Womack JH, Lamar KD, Ogles M, Patterson AL, Wake RW, Derweesh IH. Association of cerebrovascular accident and myocardial infarction with androgen deprivation therapy. Presented at the American Urological Association, 102nd Annual Meeting, Anaheim, Ca, May 2007. 56. Derweesh IH, Malcolm JB, DiBlasio CJ, Giem A, Wake RW, Patterson AL, Gold R. Laparoscopic cryoablation versus CT-guided percutaneous cryoablation for renal tumors: Single center experience. Presented at the Southeastern Section American Urological Association 71st Annual Meeting, Orlando, Florida, March 2007. 57. Derweesh IH, DiBlasio CJ, Mehrazin R, Patterson AL. Prospective comparison of 'clampless, sutureless' nephron sparing surgery vs 'conventional' open nephron sparing surgery for renal tumors involving collecting system entry: Initial experience. Presented at the Southeastern Section American Urological Association, 71st Annual Meeting, Orlando, Florida, March 2007. 58. DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. Presented at the Southeastern Section American Urological Association, 71st Annual Meeting, Orlando, Florida, March 2007. (Podium) 59. Malcolm JB, DiBlasio CJ, Womack JH, Lamar KD, Ogles M, Patterson AL, Wake RW, Derweesh IH. Association of cerebrovascular accident and myocardial infarction with androgen deprivation therapy. Presented at the Southeastern Section American Urological Association, 71st Annual Meeting, Orlando, Florida, March 2007. 60. Giel DW, DiBlasio CJ, Noe HN, Williams MA. Outcomes following treatment of occult vesicoureteral reflux detected with positional instillation of contrast (PIC) C.J. DiBlasio; 7/7/2011; Page 12 of 17 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. cystography. Presented at the Southeastern Section American Urological Association, 71st Annual Meeting, Orlando, Florida, March 2007. DiBlasio CJ, Kendirci M, Nelson C, Guhring P, Hellstrom W, Mulhall JP. Multicenter, prospective analysis of depression and quality of life profiles in men with peyronie‟s disease. Presented at the Southeastern Section American Urological Association, 71st Annual Meeting, Orlando, Florida, March 2007. DiBlasio CJ, Malcolm JB, Linn D, Kuykendall S, Derweesh IH, Wake RW. Analysis of erectile function following primary targeted cryoablation of the prostate for clinically localized prostate cancer in a contemporary series. Presented at the Society of Urologic Oncology 7th Annual meeting, Bethesda, MD, December 2006. Derweesh IH, Chichakli R, DiBlasio CJ, and Malcolm J. Initial experience with sutureless laparoscopic partial nephrectomy for tumors with collecting system entry results and experience. Presented at the Society of Urologic Oncology 7th Annual Meeting, Bethesda, MD, December 2006. Derweesh IH, Malcolm J, DiBlasio CJ, Giem A, Wake RW, Patterson AL and Gold R. Laparoscopic versus percutaneous renal cryoblation: Single center experience. Presented at the Society of Urologic Oncology 7th Annual Meeting, Bethesda, MD, December 2006. Derweesh IH, DiBlasio CJ, Mehrazin R and Patterson AL. Prospective comparison of „clampless, sutureless‟ nephron sparing surgery vs. „conventional‟ open nephron sparing surgery for renal tumors involving collecting system entry: Initial experience. Presented at the Society of Urologic Oncology 7th Annual Meeting, Bethesda, MD, December 2006. Malcolm JB, DiBlasio CJ, Womack JH, Lamar KD, Ogles M, Patterson AL, Wake RW, Derweesh IH. Association of cerebrovascular accident and myocardial infarction with androgen deprivation therapy. Presented at the Society of Urologic Oncology 7th Annual meeting, Bethesda, MD, December 2006. DiBlasio CJ, Giel DW, Williams MA, Noe HN. Positional instillation of contrast (PIC) cystography is helpful in identifying suspected vesicoureteral reflux in the setting of negative voiding cystourethrography. Presented at the Southeastern Section American Urological Association, 70th Annual Meeting, Rio Grande, Puerto Rico, 2006. DiBlasio CJ, Snyder ME, Russo P. Supra-eleventh incision: The mini-flank approach to partial and radical nephrectomy. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#31, p. 8, 2004. Stephenson AJ, DiBlasio CJ, Eastham JA, Scardino PT, Kattan MW. Predicting the 10year probability of prostate cancer recurrence: an updated postoperative nomogram after radical retropubic prostatectomy. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#787, p. 208, 2004. DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. The absence of association between body mass index (BMI) and disease progression in clinically localized prostate cancer. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#798, p. 211, 2004. Rabbani F, DiBlasio CJ, Herr HW, Scardino PT. Accuracy of the extent of lymph node involvement found at pelvic lymphadenectomy at the time of radical prostatectomy in patients with prostate cancer. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#850, p. 225, 2004. Stephenson AJ, Scardino PT, Bianco FJ, Fearn P, DiBlasio CJ, Eastham JA. Complications and functional outcomes of salvage radical prostatectomy for radio- C.J. DiBlasio; 7/7/2011; Page 13 of 17 73. 74. 75. 76. 77. 78. 79. 80. 81. 82. 83. 84. recurrent prostate cancer. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#1460, p. 384, 2004. Cho D, DiBlasio CJ, Snyder ME, Dotan ZA, Kattan MW, Fearn P, Russo P. Contemporary management of renal cortical tumors of 7 cm or less. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., J Urol, 171:4, abstract#1781, p. 471, 2004. Stephenson AJ, Scardino PT, Bianco FJ, Fearn P, DiBlasio CJ, Mulhall JP, Eastham JA. Erectile Function Outcomes Following Salvage Radical Prostatectomy For Radio Recurrent Prostate Cancer. Presented at the Biennial Meeting Of The International Society Of Sexual Medicine, Buenos Aires, Argentina, Journal of Sexual Medicine, October 2004. DiBlasio CJ, Snyder ME, Russo P. Supra-eleventh incision: The mini-flank approach to partial and radical nephrectomy. Presented at the Society of Urologic Oncology, 4th Annual Meeting; Bethesda, MD., 2003. DiBlasio CJ, Snyder ME, Kattan MW, Russo P. Ketorolac: Safe and effective analgesia in the management of renal cortical tumors with partial nephrectomy. Presented at the Society of Urologic Oncology, 4th Annual Meeting; Bethesda, MD., 2003. Eastham JA, DiBlasio CJ, Scardino PT. Safety and efficacy of salvage radical prostatectomy for local recurrence after radiation therapy: 15-year experience. Presented at the American Association of Genitourinary Surgeons; Tucson ,AZ., 2003. Cho D, DiBlasio CJ, Snyder M, Russo P. Partial nephrectomy (PN) for renal cortical tumors 4-7 cm. Presented at the American Society of Clinical Oncology, 39th Annual Meeting; moderated poster session; Chicago, IL., 2003. DiBlasio CJ, Weiss JP, Blaivas JG. LUTS Outcome Score in Men: Comparison of Surgical and Non-Surgical Treatments. Presented at the American Urological Association, 98th Annual Meeting; Chicago, IL., J Urol, 169:4, abstract#1240, p. 319, 2003. DiBlasio CJ, Blaivas JG. Diabetes and LUTS: Dispelling the Myth. Presented at the American Urological Association, 98th Annual Meeting; Chicago, IL., J Urol, 169:4, abstract#1398, pp. 374-5, 2003. DiBlasio CJ, Fearn P, Seo HS, Kattan MW, Scardino PT. Association between number of lymph nodes removed and freedom from disease progression in patients receiving Pelvic Lymph Node Dissection during Radical Prostatectomy for Prostate Cancer. Presented at the American Urological Association, 98th Annual Meeting; Chicago, IL., J Urol., 169:4, abstract#1708, p. 456, 2003. Russo P, Snyder ME, DiBlasio CJ, Sorbellini M, Kattan MW, Motzer R, Reuter V. Changing Demographics and the Contemporary Surgical Management of Renal Cortical Tumors. Presented at the American Urological Association, 98th Annual Meeting; Chicago, IL., J Urol, 169:4, abstract#DP36, pp. 347-8, 2003. Zahalsky M, DiBlasio CJ, Lam S, Nagler H. Male Infertility on the Internet. Presented at the 58th annual meeting of the American Society of Reproductive Medicine; Seattle, WA., 2002. Paladugu R, DiBlasio CJ, Wise L. Surgical outcome in patients with Sickle Cell Disease: Successful perioperative outcome at the NYMH; Brooklyn, NY., 2001. Presentations: 1. DiBlasio CJ. A discussion of male urinary health and prostate diseases in 2009. Presented at Huntington Hospital, NY, October 1, 2009. C.J. DiBlasio; 7/7/2011; Page 14 of 17 2. DiBlasio CJ. A discussion of male urinary health and prostate diseases in 2009. Presented at New Island Hospital, NY, September 21, 2009. 3. DiBlasio CJ. Cryoablation of contemporary renal and prostate cancers. Presented at Huntington Hospital, Huntington, NY, February 4, 2009. 4. DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW. Peyronie‟s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. Accepted for presentation at the Southeastern Section American Urological Association, Mobile, AL, March 2009. (Podium) 5. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake . Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Accepted for presentation at the Southeastern Section American Urological Association, Mobile, AL, March 2009. (Poster) 6. DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Accepted for presentation at the Southeastern Section American Urological Association, Mobile, AL, March 2009. (Podium) 7. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates. Accepted for presentation at the Southeastern Section American Urological Association, Mobile, AL, March 2009. (Podium) 8. DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Accepted for presentation at the Southeastern Section American Urological Association 73rd Annual Meeting, Mobile, AL, March 2009. (Poster) 9. Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical and partial nephrectomy practice patterns during residency training. Accepted for presentation at the Southeastern Section American Urological Association, Mobile, AL, March 2009. 10. DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) 11. DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt J, Yu C, Aleman MA, Patterson AL, Wake RW, Derweesh IH, Kattan MW. Family history may not predict development of prostate cancer diagnosis: results from a contemporary screening population. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) 12. Brahmbhatt J, Mehrazin R, Aleman MA, Derweesh IH, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical prostatectomy practice patterns during C.J. DiBlasio; 7/7/2011; Page 15 of 17 13. 14. 15. 16. 17. 18. 19. 20. 21. residency training. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Increasing the number of cores removed during transrectal ultrasound-guided prostate biopsy improves cancer detection. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Peri-prostatic lidocaine anesthetic block improves cancer detection during transrectal ultrasound-guided prostate biopsy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW. Use of statin medications may decrease cancer detection rates during transrectal ultrasound-guided prostate biopsy. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ. Survey based analysis of radical nephrectomy practice patterns during residency training. Presented at the Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, December 2008. (Poster) DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake . Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. (Podium) DiBlasio CJ, Maddox MM, Mehrazin R, Malcolm JB, Aleman MA, Derweesh IH, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the American Urological Association, 103rd Annual Meeting, Orlando, FL, May 2008. (Poster) DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake . Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. Presented at the ASCO Genitourinary Cancers Symposium, San Francisco, CA, February 2008. (Poster) 22. DiBlasio CJ, Maddox MM, Mehrazin R, Malcolm JB, Aleman MA, Derweesh IH, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Presented at the ASCO Genitourinary Cancers Symposium, San Francisco, CA, February 2008. (Poster) C.J. DiBlasio; 7/7/2011; Page 16 of 17 23. DiBlasio CJ, Ganguli S, Walls K, Malcolm JB, Wan JY, Derweesh IH, Aleman MA and Wake RW. Histologic changes associated with chronic indwelling bladder catheters in a contemporary cohort of spinal cord injury patients. Presented at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. (Podium) 24. DiBlasio CJ, Maddox MM, Malcolm JB, Lamar KD, Derweesh IH, Aleman MA, and Wake RW. Voiding dysfunction following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Presented at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. (Poster) 25. DiBlasio CJ, Maddox MM, Malcolm JB, Lamar KD, Derweesh IH, Aleman MA and Wake RW. Patterns of sexual and erectile dysfunction and response to treatment following primary targeted cryoablation of the prostate for localized prostate cancer. Presented at the Southeastern Section American Urological Association 72nd Annual Meeting, San Diego, CA, March 2008. (Podium) 26. DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Mehrazin R, Wan JY, Aleman MA, Derweesh IH, Patterson AL and Wake RW. Survival outcomes in men treated with androgen deprivation therapy as primary or salvage therapy: 20 year single-center experience. Presented at the Society of Urologic Oncology 8th Annual Meeting, Bethesda, MD, November 2007. (Poster) 27. DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. Accepted for presentation at the American Urological Association, 102nd Annual Meeting, Anaheim, Ca, May 2007. (Podium) 28. DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. Accepted for presentation at the Southeastern Section AUA Annual Meeting, Orlando, Florida, March 2007. (Podium) 29. DiBlasio CJ, Kendirci M, Nelson C, Guhring P, Hellstrom W, Mulhall JP. Multicenter, prospective analysis of depression and quality of life profiles in men with peyronie‟s disease. Accepted for presentation at the Southeastern Section AUA Annual Meeting, Orlando, Florida, March 2007. (Poster) 30. DiBlasio CJ, Malcolm JB, Linn D, Kuykendall S, Derweesh IH, Wake RW. Analysis of erectile function following primary targeted cryoablation of the prostate for clinically localized prostate cancer in a contemporary series. Presented at the Society of Urologic Oncology 7th Annual meeting, Bethesda, MD, December 2006. (Poster) 31. DiBlasio CJ, Giel DW, Williams MA, and Noe HN. Positional instillation of contrast (PIC) cystography is helpful in identifying suspected vesicoureteral reflux in the setting of negative voiding cystourethrography. Presented at the American Urological Association, Southeastern section, 70th Annual Meeting; Rio Grande, Puerto Rico, 2006; (Podium) 32. DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. The absence of association between body mass index (BMI) and disease progression in clinically localized prostate cancer. C.J. DiBlasio; 7/7/2011; Page 17 of 17 33. 34. 35. 36. 37. 38. 39. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., 2004; AUA Press Program (moderated by Judd Moul, M.D.) DiBlasio CJ, Snyder ME, Russo P. Supra-eleventh incision: The mini-flank approach to partial and radical nephrectomy. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA, 2004. (Discussed poster) Stephenson AJ, DiBlasio CJ, Eastham JA, Scardino PT, Kattan MW. Predicting the 10year probability of prostate cancer recurrence: an updated postoperative nomogram after radical retropubic prostatectomy. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA, 2004. (Discussed poster) DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. The absence of association between body mass index (BMI) and disease progression in clinically localized prostate cancer. Presented at the American Urological Association, 99th Annual Meeting; San Francisco, CA., 2004. (Discussed poster) DiBlasio CJ, Snyder ME, Russo P. Supra-eleventh incision: The mini-flank approach to partial and radical nephrectomy. Presented at the Society of Urologic Oncology, 4th Annual Meeting; Bethesda, MD., 2003. (Poster) DiBlasio CJ, Snyder ME, Kattan MW, Russo P. Ketorolac: Safe and effective analgesia in the management of renal cortical tumors with partial nephrectomy. Presented at the Society of Urologic Oncology, 4th Annual Meeting; Bethesda, MD., 2003. (Poster) DiBlasio CJ, Blaivas J. Diabetes and LUTS: Dispelling the Myth. Presented at the American Urological Association 98th Annual Meeting, Chicago, IL, 2003. (Moderated poster) DiBlasio CJ, Fearn P, Seo HS, Kattan MW, Scardino PT. Association between total and positive number of lymph nodes removed, disease progression, and overall survival in patients receiving pelvic lymph node dissection and radical prostatectomy for clinically localized prostate cancer. Presented at the American Urological Association 98th Annual Meeting, Chicago, IL, 2003. (Moderated poster)